MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
707.23%
Quick Ratio
707.23%
Cash Ratio
191.62%
Unit: Dollar
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Amounts receivable and prepaid e...
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Share capital of no par value a...
    • Warrant reserve
    • Others
Balance Sheets
2026-04-30
2025-10-31
2025-07-31
Cash and cash equivalents
6,880,221
2,714,012
10,493,808
Short-term investments
15,924,204
7,461,960
7,372,473
Amounts receivable and prepaid expenses
2,588,749
1,172,435
2,060,295
Total current assets
25,393,174
11,348,407
19,926,576
Equity investment in bc therapeutics
750,982
554,448
524,278
Intangible assets, net
173,072
180,707
184,525
Property and equipment, net
348,997
273,980
296,819
Long term prepaid expenses
405,085
717,508
717,508
Total non-current assets
1,678,136
1,726,643
1,723,130
Total assets
27,071,310
13,075,050
21,649,706
Trade payables
2,174,437
2,128,915
3,283,703
Accrued expenses and other payables
1,416,059
1,188,858
694,285
Total current liabilities
3,590,496
3,317,773
3,977,988
Warrant liability
71,854
406,873
337,672
Total non-current liabilities
71,854
406,873
337,672
Share capital of no par value authorized unlimited at april 30, 2026 and july 31, 2025 issued and outstanding 7,250,487 shares at april 30, 2026 and 1,883,906 july 31, 2025, respectively
117,117,225
101,739,923
101,739,923
Share-based payment reserved
11,202,809
10,610,826
10,316,140
Warrant reserve
30,216,165
17,719,026
17,719,026
Accumulated other comprehensive loss
-138,684
-138,684
-138,684
Non-controlling interest
-649,099
-627,558
-546,795
Accumulated deficit
-134,339,456
-119,953,129
-111,755,564
Total shareholders equity
23,408,960
9,350,404
17,334,046
Total liabilities and shareholders equity
27,071,310
13,075,050
21,649,706
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$15,924,204 Cash and cashequivalents$6,880,221 Amounts receivable andprepaid expenses$2,588,749 Equity investment in bctherapeutics$750,982 Long term prepaidexpenses$405,085 Property and equipment,net$348,997 Intangible assets, net$173,072 Total current assets$25,393,174 Total non-currentassets$1,678,136 Total assets$27,071,310 Total liabilities andshareholders equity$27,071,310 Total shareholdersequity$23,408,960 Total currentliabilities$3,590,496 Total non-currentliabilities$71,854 Accumulated deficit-$134,339,456 Non-controlling interest-$649,099 Accumulated othercomprehensive loss-$138,684 Share capital of no parvalue authorized...$117,117,225 Trade payables$2,174,437 Accrued expenses andother payables$1,416,059 Warrant liability$71,854 Warrant reserve$30,216,165 Share-based paymentreserved$11,202,809

BriaCell Therapeutics Corp. (BCTXZ)

BriaCell Therapeutics Corp. (BCTXZ)